Loading…
Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial
Summary Background In developing countries, mortality in children with very severe pneumonia is high, even with the provision of appropriate antibiotics, standard oxygen therapy, and other supportive care. We assessed whether oxygen therapy delivered by bubble continuous positive airway pressure (CP...
Saved in:
Published in: | The Lancet (British edition) 2015-09, Vol.386 (9998), p.1057-1065 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233 |
---|---|
cites | cdi_FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233 |
container_end_page | 1065 |
container_issue | 9998 |
container_start_page | 1057 |
container_title | The Lancet (British edition) |
container_volume | 386 |
creator | Chisti, Mohammod J, PhD Salam, Mohammed A, MBBS Smith, Jonathan H, FRCA Ahmed, Tahmeed, Prof Pietroni, Mark A C, Prof Shahunja, K M, MBBS Shahid, Abu S M S B, MBBS Faruque, Abu S G, MPH Ashraf, Hasan, MD Bardhan, Pradip K, MD Sharifuzzaman, MBBS Graham, Stephen M, Prof Duke, Trevor, Prof |
description | Summary Background In developing countries, mortality in children with very severe pneumonia is high, even with the provision of appropriate antibiotics, standard oxygen therapy, and other supportive care. We assessed whether oxygen therapy delivered by bubble continuous positive airway pressure (CPAP) improved outcomes compared with standard low-flow and high-flow oxygen therapies. Methods This open, randomised, controlled trial took place in Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh. We randomly assigned children younger than 5 years with severe pneumonia and hypoxaemia to receive oxygen therapy by either bubble CPAP (5 L/min starting at a CPAP level of 5 cm H2 O), standard low-flow nasal cannula (2 L/min), or high-flow nasal cannula (2 L/kg per min up to the maximum of 12 L/min). Randomisation was done with use of the permuted block methods (block size of 15 patients) and Fisher and Yates tables of random permutations. The primary outcome was treatment failure (ie, clinical failure, intubation and mechanical ventilation, death, or termination of hospital stay against medical advice) after more than 1 h of treatment. Primary and safety analyses were by intention to treat. We did two interim analyses and stopped the trial after the second interim analysis on Aug 3, 2013, as directed by the data safety and monitoring board. This trial is registered at ClinicalTrials.gov , number NCT01396759. Findings Between Aug 4, 2011, and July 17, 2013, 225 eligible children were recruited. We randomly allocated 79 (35%) children to receive oxygen therapy by bubble CPAP, 67 (30%) to low-flow oxygen therapy, and 79 (35%) to high-flow oxygen therapy. Treatment failed for 31 (14%) children, of whom five (6%) had received bubble CPAP, 16 (24%) had received low-flow oxygen therapy, and ten (13%) had received high-flow oxygen therapy. Significantly fewer children in the bubble CPAP group had treatment failure than in the low-flow oxygen therapy group (relative risk [RR] 0·27, 99·7% CI 0·07–0·99; p=0·0026). No difference in treatment failure was noted between patients in the bubble CPAP and those in the high-flow oxygen therapy group (RR 0·50, 99·7% 0·11–2·29; p=0·175). 23 (10%) children died. Three (4%) children died in the bubble CPAP group, ten (15%) children died in the low-flow oxygen therapy group, and ten (13%) children died in the high-flow oxygen therapy group. Children who received oxygen by bubble CPAP had significantly l |
doi_str_mv | 10.1016/S0140-6736(15)60249-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1747341531</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0140673615602495</els_id><sourcerecordid>3803882281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233</originalsourceid><addsrcrecordid>eNqNks1u1DAQxy0EosvCI4AscSkSATuO7aQHEK34kipxACRulmNPWJfEDnayZd-CR8bZLUXqpZxsz_zmP54PhB5T8oISKl5-JrQihZBMHFP-TJCyagp-B61oJauCV_LbXbS6Ro7Qg5QuCCGVIPw-OipF2YiGkxX6fTq3bQ_YBD85P4c54TEkN7ktYO3ipd7hMUJKcwTchYjNxvU2gseXbtrgBFvIjtHDPATvNNbe4s1uDL80DPnpPD7V_nuvLaTNSfbiMIJ_jmPmwuAS2H3iGPo-X6fodP8Q3et0n-DR1blGX9-9_XL2oTj_9P7j2ZvzwggmpoJ3QhvK6lZL2tWkKbmV0EgJtqZEatFVvG4J55bZsmSipl1lobOtLrU02cLW6PigO8bwc4Y0qfwfA32vPeQuKCorySrKGf0PlJV1zpE7fTtKWVPJMuuu0dMb6EWYo881LxQlgtFyofiBMjGkFKFTY3SDjjtFiVoWQe0XQS1TVpSr_SKoJe7JlfrcDmCvo_5OPgOvDwDkJm8dRJWMA2_AughmUja4W1O8uqFgeued0f0P2EH6V41KpSIHkUWD8r0CZ38AL-zYkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1711063125</pqid></control><display><type>article</type><title>Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Chisti, Mohammod J, PhD ; Salam, Mohammed A, MBBS ; Smith, Jonathan H, FRCA ; Ahmed, Tahmeed, Prof ; Pietroni, Mark A C, Prof ; Shahunja, K M, MBBS ; Shahid, Abu S M S B, MBBS ; Faruque, Abu S G, MPH ; Ashraf, Hasan, MD ; Bardhan, Pradip K, MD ; Sharifuzzaman, MBBS ; Graham, Stephen M, Prof ; Duke, Trevor, Prof</creator><creatorcontrib>Chisti, Mohammod J, PhD ; Salam, Mohammed A, MBBS ; Smith, Jonathan H, FRCA ; Ahmed, Tahmeed, Prof ; Pietroni, Mark A C, Prof ; Shahunja, K M, MBBS ; Shahid, Abu S M S B, MBBS ; Faruque, Abu S G, MPH ; Ashraf, Hasan, MD ; Bardhan, Pradip K, MD ; Sharifuzzaman, MBBS ; Graham, Stephen M, Prof ; Duke, Trevor, Prof</creatorcontrib><description>Summary Background In developing countries, mortality in children with very severe pneumonia is high, even with the provision of appropriate antibiotics, standard oxygen therapy, and other supportive care. We assessed whether oxygen therapy delivered by bubble continuous positive airway pressure (CPAP) improved outcomes compared with standard low-flow and high-flow oxygen therapies. Methods This open, randomised, controlled trial took place in Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh. We randomly assigned children younger than 5 years with severe pneumonia and hypoxaemia to receive oxygen therapy by either bubble CPAP (5 L/min starting at a CPAP level of 5 cm H2 O), standard low-flow nasal cannula (2 L/min), or high-flow nasal cannula (2 L/kg per min up to the maximum of 12 L/min). Randomisation was done with use of the permuted block methods (block size of 15 patients) and Fisher and Yates tables of random permutations. The primary outcome was treatment failure (ie, clinical failure, intubation and mechanical ventilation, death, or termination of hospital stay against medical advice) after more than 1 h of treatment. Primary and safety analyses were by intention to treat. We did two interim analyses and stopped the trial after the second interim analysis on Aug 3, 2013, as directed by the data safety and monitoring board. This trial is registered at ClinicalTrials.gov , number NCT01396759. Findings Between Aug 4, 2011, and July 17, 2013, 225 eligible children were recruited. We randomly allocated 79 (35%) children to receive oxygen therapy by bubble CPAP, 67 (30%) to low-flow oxygen therapy, and 79 (35%) to high-flow oxygen therapy. Treatment failed for 31 (14%) children, of whom five (6%) had received bubble CPAP, 16 (24%) had received low-flow oxygen therapy, and ten (13%) had received high-flow oxygen therapy. Significantly fewer children in the bubble CPAP group had treatment failure than in the low-flow oxygen therapy group (relative risk [RR] 0·27, 99·7% CI 0·07–0·99; p=0·0026). No difference in treatment failure was noted between patients in the bubble CPAP and those in the high-flow oxygen therapy group (RR 0·50, 99·7% 0·11–2·29; p=0·175). 23 (10%) children died. Three (4%) children died in the bubble CPAP group, ten (15%) children died in the low-flow oxygen therapy group, and ten (13%) children died in the high-flow oxygen therapy group. Children who received oxygen by bubble CPAP had significantly lower rates of death than the children who received oxygen by low-flow oxygen therapy (RR 0·25, 95% CI 0·07–0·89; p=0·022). Interpretation Oxygen therapy delivered by bubble CPAP improved outcomes in Bangladeshi children with very severe pneumonia and hypoxaemia compared with standard low-flow oxygen therapy. Use of bubble CPAP oxygen therapy could have a large effect in hospitals in developing countries where the only respiratory support for severe childhood pneumonia and hypoxaemia is low-flow oxygen therapy. The trial was stopped early because of higher mortality in the low-flow oxygen group than in the bubble CPAP group, and we acknowledge that the early cessation of the trial reduces the certainty of the findings. Further research is needed to test the feasibility of scaling up bubble CPAP in district hospitals and to improve bubble CPAP delivery technology. Funding International Centre for Diarrhoeal Disease Research, Bangladesh, and Centre for International Child Health, University of Melbourne.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(15)60249-5</identifier><identifier>PMID: 26296950</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibiotics ; Bangladesh ; Children & youth ; Continuous positive airway pressure ; Continuous Positive Airway Pressure - methods ; Developing Countries ; Female ; Hospitals ; Humans ; Hypoxia ; Hypoxia - microbiology ; Hypoxia - therapy ; Infant ; Internal Medicine ; LDCs ; Length of Stay - statistics & numerical data ; Male ; Mortality ; Oxygen ; Oxygen Inhalation Therapy - methods ; Pneumonia ; Pneumonia - complications ; Pneumonia - therapy ; Respiratory therapy ; Treatment Outcome</subject><ispartof>The Lancet (British edition), 2015-09, Vol.386 (9998), p.1057-1065</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 12, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233</citedby><cites>FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26296950$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chisti, Mohammod J, PhD</creatorcontrib><creatorcontrib>Salam, Mohammed A, MBBS</creatorcontrib><creatorcontrib>Smith, Jonathan H, FRCA</creatorcontrib><creatorcontrib>Ahmed, Tahmeed, Prof</creatorcontrib><creatorcontrib>Pietroni, Mark A C, Prof</creatorcontrib><creatorcontrib>Shahunja, K M, MBBS</creatorcontrib><creatorcontrib>Shahid, Abu S M S B, MBBS</creatorcontrib><creatorcontrib>Faruque, Abu S G, MPH</creatorcontrib><creatorcontrib>Ashraf, Hasan, MD</creatorcontrib><creatorcontrib>Bardhan, Pradip K, MD</creatorcontrib><creatorcontrib>Sharifuzzaman, MBBS</creatorcontrib><creatorcontrib>Graham, Stephen M, Prof</creatorcontrib><creatorcontrib>Duke, Trevor, Prof</creatorcontrib><title>Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Summary Background In developing countries, mortality in children with very severe pneumonia is high, even with the provision of appropriate antibiotics, standard oxygen therapy, and other supportive care. We assessed whether oxygen therapy delivered by bubble continuous positive airway pressure (CPAP) improved outcomes compared with standard low-flow and high-flow oxygen therapies. Methods This open, randomised, controlled trial took place in Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh. We randomly assigned children younger than 5 years with severe pneumonia and hypoxaemia to receive oxygen therapy by either bubble CPAP (5 L/min starting at a CPAP level of 5 cm H2 O), standard low-flow nasal cannula (2 L/min), or high-flow nasal cannula (2 L/kg per min up to the maximum of 12 L/min). Randomisation was done with use of the permuted block methods (block size of 15 patients) and Fisher and Yates tables of random permutations. The primary outcome was treatment failure (ie, clinical failure, intubation and mechanical ventilation, death, or termination of hospital stay against medical advice) after more than 1 h of treatment. Primary and safety analyses were by intention to treat. We did two interim analyses and stopped the trial after the second interim analysis on Aug 3, 2013, as directed by the data safety and monitoring board. This trial is registered at ClinicalTrials.gov , number NCT01396759. Findings Between Aug 4, 2011, and July 17, 2013, 225 eligible children were recruited. We randomly allocated 79 (35%) children to receive oxygen therapy by bubble CPAP, 67 (30%) to low-flow oxygen therapy, and 79 (35%) to high-flow oxygen therapy. Treatment failed for 31 (14%) children, of whom five (6%) had received bubble CPAP, 16 (24%) had received low-flow oxygen therapy, and ten (13%) had received high-flow oxygen therapy. Significantly fewer children in the bubble CPAP group had treatment failure than in the low-flow oxygen therapy group (relative risk [RR] 0·27, 99·7% CI 0·07–0·99; p=0·0026). No difference in treatment failure was noted between patients in the bubble CPAP and those in the high-flow oxygen therapy group (RR 0·50, 99·7% 0·11–2·29; p=0·175). 23 (10%) children died. Three (4%) children died in the bubble CPAP group, ten (15%) children died in the low-flow oxygen therapy group, and ten (13%) children died in the high-flow oxygen therapy group. Children who received oxygen by bubble CPAP had significantly lower rates of death than the children who received oxygen by low-flow oxygen therapy (RR 0·25, 95% CI 0·07–0·89; p=0·022). Interpretation Oxygen therapy delivered by bubble CPAP improved outcomes in Bangladeshi children with very severe pneumonia and hypoxaemia compared with standard low-flow oxygen therapy. Use of bubble CPAP oxygen therapy could have a large effect in hospitals in developing countries where the only respiratory support for severe childhood pneumonia and hypoxaemia is low-flow oxygen therapy. The trial was stopped early because of higher mortality in the low-flow oxygen group than in the bubble CPAP group, and we acknowledge that the early cessation of the trial reduces the certainty of the findings. Further research is needed to test the feasibility of scaling up bubble CPAP in district hospitals and to improve bubble CPAP delivery technology. Funding International Centre for Diarrhoeal Disease Research, Bangladesh, and Centre for International Child Health, University of Melbourne.</description><subject>Antibiotics</subject><subject>Bangladesh</subject><subject>Children & youth</subject><subject>Continuous positive airway pressure</subject><subject>Continuous Positive Airway Pressure - methods</subject><subject>Developing Countries</subject><subject>Female</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia - microbiology</subject><subject>Hypoxia - therapy</subject><subject>Infant</subject><subject>Internal Medicine</subject><subject>LDCs</subject><subject>Length of Stay - statistics & numerical data</subject><subject>Male</subject><subject>Mortality</subject><subject>Oxygen</subject><subject>Oxygen Inhalation Therapy - methods</subject><subject>Pneumonia</subject><subject>Pneumonia - complications</subject><subject>Pneumonia - therapy</subject><subject>Respiratory therapy</subject><subject>Treatment Outcome</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNks1u1DAQxy0EosvCI4AscSkSATuO7aQHEK34kipxACRulmNPWJfEDnayZd-CR8bZLUXqpZxsz_zmP54PhB5T8oISKl5-JrQihZBMHFP-TJCyagp-B61oJauCV_LbXbS6Ro7Qg5QuCCGVIPw-OipF2YiGkxX6fTq3bQ_YBD85P4c54TEkN7ktYO3ipd7hMUJKcwTchYjNxvU2gseXbtrgBFvIjtHDPATvNNbe4s1uDL80DPnpPD7V_nuvLaTNSfbiMIJ_jmPmwuAS2H3iGPo-X6fodP8Q3et0n-DR1blGX9-9_XL2oTj_9P7j2ZvzwggmpoJ3QhvK6lZL2tWkKbmV0EgJtqZEatFVvG4J55bZsmSipl1lobOtLrU02cLW6PigO8bwc4Y0qfwfA32vPeQuKCorySrKGf0PlJV1zpE7fTtKWVPJMuuu0dMb6EWYo881LxQlgtFyofiBMjGkFKFTY3SDjjtFiVoWQe0XQS1TVpSr_SKoJe7JlfrcDmCvo_5OPgOvDwDkJm8dRJWMA2_AughmUja4W1O8uqFgeued0f0P2EH6V41KpSIHkUWD8r0CZ38AL-zYkw</recordid><startdate>20150912</startdate><enddate>20150912</enddate><creator>Chisti, Mohammod J, PhD</creator><creator>Salam, Mohammed A, MBBS</creator><creator>Smith, Jonathan H, FRCA</creator><creator>Ahmed, Tahmeed, Prof</creator><creator>Pietroni, Mark A C, Prof</creator><creator>Shahunja, K M, MBBS</creator><creator>Shahid, Abu S M S B, MBBS</creator><creator>Faruque, Abu S G, MPH</creator><creator>Ashraf, Hasan, MD</creator><creator>Bardhan, Pradip K, MD</creator><creator>Sharifuzzaman, MBBS</creator><creator>Graham, Stephen M, Prof</creator><creator>Duke, Trevor, Prof</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope></search><sort><creationdate>20150912</creationdate><title>Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial</title><author>Chisti, Mohammod J, PhD ; Salam, Mohammed A, MBBS ; Smith, Jonathan H, FRCA ; Ahmed, Tahmeed, Prof ; Pietroni, Mark A C, Prof ; Shahunja, K M, MBBS ; Shahid, Abu S M S B, MBBS ; Faruque, Abu S G, MPH ; Ashraf, Hasan, MD ; Bardhan, Pradip K, MD ; Sharifuzzaman, MBBS ; Graham, Stephen M, Prof ; Duke, Trevor, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antibiotics</topic><topic>Bangladesh</topic><topic>Children & youth</topic><topic>Continuous positive airway pressure</topic><topic>Continuous Positive Airway Pressure - methods</topic><topic>Developing Countries</topic><topic>Female</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia - microbiology</topic><topic>Hypoxia - therapy</topic><topic>Infant</topic><topic>Internal Medicine</topic><topic>LDCs</topic><topic>Length of Stay - statistics & numerical data</topic><topic>Male</topic><topic>Mortality</topic><topic>Oxygen</topic><topic>Oxygen Inhalation Therapy - methods</topic><topic>Pneumonia</topic><topic>Pneumonia - complications</topic><topic>Pneumonia - therapy</topic><topic>Respiratory therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chisti, Mohammod J, PhD</creatorcontrib><creatorcontrib>Salam, Mohammed A, MBBS</creatorcontrib><creatorcontrib>Smith, Jonathan H, FRCA</creatorcontrib><creatorcontrib>Ahmed, Tahmeed, Prof</creatorcontrib><creatorcontrib>Pietroni, Mark A C, Prof</creatorcontrib><creatorcontrib>Shahunja, K M, MBBS</creatorcontrib><creatorcontrib>Shahid, Abu S M S B, MBBS</creatorcontrib><creatorcontrib>Faruque, Abu S G, MPH</creatorcontrib><creatorcontrib>Ashraf, Hasan, MD</creatorcontrib><creatorcontrib>Bardhan, Pradip K, MD</creatorcontrib><creatorcontrib>Sharifuzzaman, MBBS</creatorcontrib><creatorcontrib>Graham, Stephen M, Prof</creatorcontrib><creatorcontrib>Duke, Trevor, Prof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Health Management Database (Proquest)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chisti, Mohammod J, PhD</au><au>Salam, Mohammed A, MBBS</au><au>Smith, Jonathan H, FRCA</au><au>Ahmed, Tahmeed, Prof</au><au>Pietroni, Mark A C, Prof</au><au>Shahunja, K M, MBBS</au><au>Shahid, Abu S M S B, MBBS</au><au>Faruque, Abu S G, MPH</au><au>Ashraf, Hasan, MD</au><au>Bardhan, Pradip K, MD</au><au>Sharifuzzaman, MBBS</au><au>Graham, Stephen M, Prof</au><au>Duke, Trevor, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2015-09-12</date><risdate>2015</risdate><volume>386</volume><issue>9998</issue><spage>1057</spage><epage>1065</epage><pages>1057-1065</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Summary Background In developing countries, mortality in children with very severe pneumonia is high, even with the provision of appropriate antibiotics, standard oxygen therapy, and other supportive care. We assessed whether oxygen therapy delivered by bubble continuous positive airway pressure (CPAP) improved outcomes compared with standard low-flow and high-flow oxygen therapies. Methods This open, randomised, controlled trial took place in Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh. We randomly assigned children younger than 5 years with severe pneumonia and hypoxaemia to receive oxygen therapy by either bubble CPAP (5 L/min starting at a CPAP level of 5 cm H2 O), standard low-flow nasal cannula (2 L/min), or high-flow nasal cannula (2 L/kg per min up to the maximum of 12 L/min). Randomisation was done with use of the permuted block methods (block size of 15 patients) and Fisher and Yates tables of random permutations. The primary outcome was treatment failure (ie, clinical failure, intubation and mechanical ventilation, death, or termination of hospital stay against medical advice) after more than 1 h of treatment. Primary and safety analyses were by intention to treat. We did two interim analyses and stopped the trial after the second interim analysis on Aug 3, 2013, as directed by the data safety and monitoring board. This trial is registered at ClinicalTrials.gov , number NCT01396759. Findings Between Aug 4, 2011, and July 17, 2013, 225 eligible children were recruited. We randomly allocated 79 (35%) children to receive oxygen therapy by bubble CPAP, 67 (30%) to low-flow oxygen therapy, and 79 (35%) to high-flow oxygen therapy. Treatment failed for 31 (14%) children, of whom five (6%) had received bubble CPAP, 16 (24%) had received low-flow oxygen therapy, and ten (13%) had received high-flow oxygen therapy. Significantly fewer children in the bubble CPAP group had treatment failure than in the low-flow oxygen therapy group (relative risk [RR] 0·27, 99·7% CI 0·07–0·99; p=0·0026). No difference in treatment failure was noted between patients in the bubble CPAP and those in the high-flow oxygen therapy group (RR 0·50, 99·7% 0·11–2·29; p=0·175). 23 (10%) children died. Three (4%) children died in the bubble CPAP group, ten (15%) children died in the low-flow oxygen therapy group, and ten (13%) children died in the high-flow oxygen therapy group. Children who received oxygen by bubble CPAP had significantly lower rates of death than the children who received oxygen by low-flow oxygen therapy (RR 0·25, 95% CI 0·07–0·89; p=0·022). Interpretation Oxygen therapy delivered by bubble CPAP improved outcomes in Bangladeshi children with very severe pneumonia and hypoxaemia compared with standard low-flow oxygen therapy. Use of bubble CPAP oxygen therapy could have a large effect in hospitals in developing countries where the only respiratory support for severe childhood pneumonia and hypoxaemia is low-flow oxygen therapy. The trial was stopped early because of higher mortality in the low-flow oxygen group than in the bubble CPAP group, and we acknowledge that the early cessation of the trial reduces the certainty of the findings. Further research is needed to test the feasibility of scaling up bubble CPAP in district hospitals and to improve bubble CPAP delivery technology. Funding International Centre for Diarrhoeal Disease Research, Bangladesh, and Centre for International Child Health, University of Melbourne.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26296950</pmid><doi>10.1016/S0140-6736(15)60249-5</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-6736 |
ispartof | The Lancet (British edition), 2015-09, Vol.386 (9998), p.1057-1065 |
issn | 0140-6736 1474-547X |
language | eng |
recordid | cdi_proquest_miscellaneous_1747341531 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Antibiotics Bangladesh Children & youth Continuous positive airway pressure Continuous Positive Airway Pressure - methods Developing Countries Female Hospitals Humans Hypoxia Hypoxia - microbiology Hypoxia - therapy Infant Internal Medicine LDCs Length of Stay - statistics & numerical data Male Mortality Oxygen Oxygen Inhalation Therapy - methods Pneumonia Pneumonia - complications Pneumonia - therapy Respiratory therapy Treatment Outcome |
title | Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A54%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bubble%20continuous%20positive%20airway%20pressure%20for%20children%20with%20severe%20pneumonia%20and%20hypoxaemia%20in%20Bangladesh:%20an%20open,%20randomised%20controlled%20trial&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Chisti,%20Mohammod%20J,%20PhD&rft.date=2015-09-12&rft.volume=386&rft.issue=9998&rft.spage=1057&rft.epage=1065&rft.pages=1057-1065&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(15)60249-5&rft_dat=%3Cproquest_cross%3E3803882281%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c636t-5f6ac138ba71f80925d7e977ed8107a6f458b055d3d223681f4defdba2a7c2233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1711063125&rft_id=info:pmid/26296950&rfr_iscdi=true |